NCT07909122
Real-World Treatment Patterns and Effectiveness of Anti-EGFR- and Anti-VEGF-based Therapies in Left-sided RAS Wild-Type Metastatic Colorectal Cancer
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
First-Line Treatment Patterns
Timeframe: Up to approximately 13 years, 9 months
Real-World Overall Survival (rwOS)
Timeframe: Up to approximately 13 years, 9 months.
Secondary (2)
Treatment patterns following 1L therapy
Real-world effectiveness across lines of therapy
Arms and interventions
Anti-EGFR-Based Therapy Cohort
Patients initiating first-line anti-EGFR therapy combined with standard chemotherapy.
Anti-VEGF-Based Therapy Cohort
Patients initiating first-line anti-VEGF therapy combined with standard chemotherapy.
Drugs: Anti-EGFR-Based Therapy, Anti-VEGF-Based Therapy